Zomedica Corp (ZOMDF)

$0.05 -0.05 (-50.67%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 90,549,906
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. It provides therapeutic products, including PulseVet electrohydraulic sho...

Industry: Medical Devices
Sector: Healthcare
Phone: 734 369 2555
Address:
100 Phoenix Drive, Suite 190, Ann Arbor, United States
Zell1980
Zell1980 Jul. 13 at 3:35 AM
$ZOMDF Alright folks, I’m officially done for the day. My thumbs need a nap -_-" Appreciate everyone who took the time to read through my posts. I know I dropped a bunch, so if it felt like spam… just pretend I was typing really slowly all day. Not here to pump, just to keep us informed and connected. Hope something I shared helped someone out.
0 · Reply
Zell1980
Zell1980 Jul. 13 at 3:29 AM
$ZOMDF I’m Zell1980, and I post to inform and engage, not pump. I want everyone, especially new investors, to see what’s here and what could be coming. Yes, Zomedica is speculative. Yes, the stock is down. But this is a long term play, not a get rich quick scheme. IF execution goes well with TruView’s full rollout, PulseVet expansion, VetGuardian adoption, and Truforma growth we could start seeing signs of meaningful traction in 12–18 months, with more noticeable impact potentially by 2027. Think of it like this: Zomedica doesn't have to be the next IDEXX, it just needs to claim a sliver of the $12B+ vet diagnostics and tech market to be a major win at these levels. I'm not here to spam. I’m here to help inform and spark steady support. Slow growth. Strong hands. Silent readers: you're not alone.
0 · Reply
Zell1980
Zell1980 Jul. 13 at 3:08 AM
$ZOMDF I know a lot of you out there are just watching, not posting, not arguing, just reading. To all the silent bulls, the ones quietly holding $ZOMDF through the noise: I see you. And you’re not alone. I’m posting not to hype, but to keep the facts visible: TruView is launching soon PulseVet is already generating revenue VetGuardian and Vetigel are real tech with real purpose ZOM has ~$60M in cash and no debt Execution is the last piece and that’s finally in motion You don’t have to post, but stay focused. Stay patient. Because when this story flips, the loudest won’t be the only ones rewarded. The quiet ones holding strong will be right there, too.
0 · Reply
Zell1980
Zell1980 Jul. 13 at 2:49 AM
$ZOMDF Let me be clear!! I’m not here to pump $ZOMDF or start a hype train. I’ve been holding since 2021, and everything I post is based on real company updates, filings, and product developments. I’m not spamming or trying to manipulate anyone. I’m here to inform newcomers and help other bulls stay engaged with the bigger picture. Zomedica isn’t just a ticker. It’s a real company I’m not here for hype. I’m here because I believe "IF!!!" ZOM executes, it can carve out its own space in the vet care worldp and that alone can drive steady, real shareholder growth. So if you’re long, speak up. Let’s build this together not with FOMO, but with focus and facts.
0 · Reply
Zell1980
Zell1980 Jul. 13 at 1:09 AM
$ZOMDF Part 2 5. Company strength ~$60M in cash No debt Focused strategy to serve under supported clinics not trying to out IDEXX Zomedica is not a meme. It’s not hype. It’s a diversified, cash loaded veterinary tech company with real tools solving real problems. Execution is the last piece. And we’re watching that unfold right now. Let’s see what Monday brings.
0 · Reply
Zell1980
Zell1980 Jul. 13 at 1:09 AM
$ZOMDF Part 1 For anyone sleeping on $ZOMDF, here’s the REAL story: 1. TruView Launching soon Automated cytology slide prep plus remote board-certified pathology Vendor-neutral, no subscription, plug and play perfect for independent clinics “Weeks out” per CEO Larry Heaton 2. PulseVet Already in market Official shockwave therapy device at World Equestrian Center Used in equine sports medicine to reduce inflammation & speed healing Recurring revenue model already active 3. VetGuardian Contactless vital signs monitoring Real-time respiratory, heart rate, and temp tracking no wires, no stress Ideal for post op monitoring, emergency cases, and mobile vets Already seeing early adoption 4. Vetigel Coming early 2025 Plant based gel that stops bleeding in seconds Targeting the $1.4B+ global hemostasis market Surgical, dental, and trauma ready huge TAM and clinical edge
0 · Reply
Zell1980
Zell1980 Jul. 12 at 9:48 PM
$ZOMDF Most people still don’t understand what’s coming with TruView but here’s why it matters: Automated cytology slide prep plus remote board certified pathology reviews all in one device. Designed for general vet clinics that don’t have pathologists or don’t want to be locked into IDEXX or Zoetis ecosystems. Fully vendor neutral, plug and play, and built for speed, affordability, and flexibility. Still in pre launch phase so judging “demand” now is like critiquing a movie before release. TruView isn’t trying to be IDEXX. It’s targeting the massive, underserved segment of clinics that need diagnostics without the cost, contracts, or complexity. If Zomedica executes, TruView alone could change the game for smaller practices… and for shareholders who see what’s coming.
0 · Reply
Zell1980
Zell1980 Jul. 12 at 9:41 PM
$ZOMDF Funny how people keep calling TruView “inferior” before it’s even launched. That’s like declaring a race over before the gates open. TruView was never about replacing IDEXX or Zoetis head on. It’s about giving clinics, especially smaller or independent ones, a vendor neutral, affordable, automated cytology option with remote board certified pathology support. Not every vet clinic wants or can afford to be locked into an IDEXX ecosystem with all the bundled analyzers, subscriptions, and contracts. There’s a huge underserved segment Zomedica is smart to target. Call it “second class” all you want, but in business, filling the right gap beats chasing the giant. If ZOM executes, TruView won’t need to beat IDEXX just carve its piece of the pie. That alone can be a win for long term holders.
0 · Reply
Zell1980
Zell1980 Jul. 12 at 2:03 AM
$ZOMDF Not every win has to be a takeover. Zomedica doesn’t need to become the next IDEXX or Zoetis. It just needs to execute well, serve its niche, and carve out its piece of the pie. TruView won’t replace big box diagnostics, but it can serve clinics that want simpler, more affordable solutions. PulseVet is already strong in equine. VetGuardian offers a contactless edge. Vetigel adds a recurring product with clinical use. No debt. $60M cash. Multiple markets. Slow growth. Real traction. That’s still a win for you bulls.
1 · Reply
investnincrease
investnincrease Jul. 11 at 11:55 PM
$ZOMDF 😨
1 · Reply
Latest News on ZOMDF
No data available.
Zell1980
Zell1980 Jul. 13 at 3:35 AM
$ZOMDF Alright folks, I’m officially done for the day. My thumbs need a nap -_-" Appreciate everyone who took the time to read through my posts. I know I dropped a bunch, so if it felt like spam… just pretend I was typing really slowly all day. Not here to pump, just to keep us informed and connected. Hope something I shared helped someone out.
0 · Reply
Zell1980
Zell1980 Jul. 13 at 3:29 AM
$ZOMDF I’m Zell1980, and I post to inform and engage, not pump. I want everyone, especially new investors, to see what’s here and what could be coming. Yes, Zomedica is speculative. Yes, the stock is down. But this is a long term play, not a get rich quick scheme. IF execution goes well with TruView’s full rollout, PulseVet expansion, VetGuardian adoption, and Truforma growth we could start seeing signs of meaningful traction in 12–18 months, with more noticeable impact potentially by 2027. Think of it like this: Zomedica doesn't have to be the next IDEXX, it just needs to claim a sliver of the $12B+ vet diagnostics and tech market to be a major win at these levels. I'm not here to spam. I’m here to help inform and spark steady support. Slow growth. Strong hands. Silent readers: you're not alone.
0 · Reply
Zell1980
Zell1980 Jul. 13 at 3:08 AM
$ZOMDF I know a lot of you out there are just watching, not posting, not arguing, just reading. To all the silent bulls, the ones quietly holding $ZOMDF through the noise: I see you. And you’re not alone. I’m posting not to hype, but to keep the facts visible: TruView is launching soon PulseVet is already generating revenue VetGuardian and Vetigel are real tech with real purpose ZOM has ~$60M in cash and no debt Execution is the last piece and that’s finally in motion You don’t have to post, but stay focused. Stay patient. Because when this story flips, the loudest won’t be the only ones rewarded. The quiet ones holding strong will be right there, too.
0 · Reply
Zell1980
Zell1980 Jul. 13 at 2:49 AM
$ZOMDF Let me be clear!! I’m not here to pump $ZOMDF or start a hype train. I’ve been holding since 2021, and everything I post is based on real company updates, filings, and product developments. I’m not spamming or trying to manipulate anyone. I’m here to inform newcomers and help other bulls stay engaged with the bigger picture. Zomedica isn’t just a ticker. It’s a real company I’m not here for hype. I’m here because I believe "IF!!!" ZOM executes, it can carve out its own space in the vet care worldp and that alone can drive steady, real shareholder growth. So if you’re long, speak up. Let’s build this together not with FOMO, but with focus and facts.
0 · Reply
Zell1980
Zell1980 Jul. 13 at 1:09 AM
$ZOMDF Part 2 5. Company strength ~$60M in cash No debt Focused strategy to serve under supported clinics not trying to out IDEXX Zomedica is not a meme. It’s not hype. It’s a diversified, cash loaded veterinary tech company with real tools solving real problems. Execution is the last piece. And we’re watching that unfold right now. Let’s see what Monday brings.
0 · Reply
Zell1980
Zell1980 Jul. 13 at 1:09 AM
$ZOMDF Part 1 For anyone sleeping on $ZOMDF, here’s the REAL story: 1. TruView Launching soon Automated cytology slide prep plus remote board-certified pathology Vendor-neutral, no subscription, plug and play perfect for independent clinics “Weeks out” per CEO Larry Heaton 2. PulseVet Already in market Official shockwave therapy device at World Equestrian Center Used in equine sports medicine to reduce inflammation & speed healing Recurring revenue model already active 3. VetGuardian Contactless vital signs monitoring Real-time respiratory, heart rate, and temp tracking no wires, no stress Ideal for post op monitoring, emergency cases, and mobile vets Already seeing early adoption 4. Vetigel Coming early 2025 Plant based gel that stops bleeding in seconds Targeting the $1.4B+ global hemostasis market Surgical, dental, and trauma ready huge TAM and clinical edge
0 · Reply
Zell1980
Zell1980 Jul. 12 at 9:48 PM
$ZOMDF Most people still don’t understand what’s coming with TruView but here’s why it matters: Automated cytology slide prep plus remote board certified pathology reviews all in one device. Designed for general vet clinics that don’t have pathologists or don’t want to be locked into IDEXX or Zoetis ecosystems. Fully vendor neutral, plug and play, and built for speed, affordability, and flexibility. Still in pre launch phase so judging “demand” now is like critiquing a movie before release. TruView isn’t trying to be IDEXX. It’s targeting the massive, underserved segment of clinics that need diagnostics without the cost, contracts, or complexity. If Zomedica executes, TruView alone could change the game for smaller practices… and for shareholders who see what’s coming.
0 · Reply
Zell1980
Zell1980 Jul. 12 at 9:41 PM
$ZOMDF Funny how people keep calling TruView “inferior” before it’s even launched. That’s like declaring a race over before the gates open. TruView was never about replacing IDEXX or Zoetis head on. It’s about giving clinics, especially smaller or independent ones, a vendor neutral, affordable, automated cytology option with remote board certified pathology support. Not every vet clinic wants or can afford to be locked into an IDEXX ecosystem with all the bundled analyzers, subscriptions, and contracts. There’s a huge underserved segment Zomedica is smart to target. Call it “second class” all you want, but in business, filling the right gap beats chasing the giant. If ZOM executes, TruView won’t need to beat IDEXX just carve its piece of the pie. That alone can be a win for long term holders.
0 · Reply
Zell1980
Zell1980 Jul. 12 at 2:03 AM
$ZOMDF Not every win has to be a takeover. Zomedica doesn’t need to become the next IDEXX or Zoetis. It just needs to execute well, serve its niche, and carve out its piece of the pie. TruView won’t replace big box diagnostics, but it can serve clinics that want simpler, more affordable solutions. PulseVet is already strong in equine. VetGuardian offers a contactless edge. Vetigel adds a recurring product with clinical use. No debt. $60M cash. Multiple markets. Slow growth. Real traction. That’s still a win for you bulls.
1 · Reply
investnincrease
investnincrease Jul. 11 at 11:55 PM
$ZOMDF 😨
1 · Reply
PharmGuy
PharmGuy Jul. 11 at 8:19 PM
$ZOMDF So really, we are realistically relying on pulsevet, vetguardian, and maybe Truforma for future growth. Assisi isn’t growing but staying stagnant. Truview won’t come anything close to “selling like hot cakes” for those that remember Larry’s quote about a year/year and a half ago.
1 · Reply
Zomturd
Zomturd Jul. 11 at 8:02 PM
$ZOMDF all this fluff means nothing! Larry needs to increase revenue and lower costs. Anything below 7 million for q2 is bad
0 · Reply
PharmGuy
PharmGuy Jul. 11 at 8:01 PM
$ZOMDF not sure about Truview (haven’t been high on it for a while). But there is a product that has AI capabilities and already on the market. It’s called Vetscan Imagyst by Zoetis. https://www.zoetisus.com/products/diagnostics/instruments/vetscan-imagyst/ Looks like a sweet design. The only thing it doesn’t do is prep the slide for you, but not sure if vets really care about that 5 min saved time per slide?
2 · Reply
MyChicago
MyChicago Jul. 11 at 7:16 PM
$ZOMDF
1 · Reply
YNK
YNK Jul. 11 at 7:06 PM
$ZOMDF Would World Equestrian associate with a failing company that has nothing to offer? Zedan could be a game changer.
0 · Reply
ZomedicaPharm
ZomedicaPharm Jul. 11 at 6:44 PM
$ZOMDF
0 · Reply
ZomedicaPharm
ZomedicaPharm Jul. 11 at 6:40 PM
$ZOMDF
0 · Reply
Zell1980
Zell1980 Jul. 11 at 3:56 PM
$ZOMDF SP is under $0.05, but here's why I’m still holding strong. $60M cash on hand No debt, no dilution pressure TruView diagnostic device weeks away from launch Vetigel launching in 2025, targeting $1.4B global hemostasis market PulseVet + Assisi already used in vet clinics New partnership with World Equestrian Center (elite exposure) Global expansion now underway This isn’t a get-rich-quick stock, it’s a rebuild story. Quiet moves are stacking. Execution matters now. Patience, not panic. Not financial advice, just one retail investor sharing facts and faith.
1 · Reply
Afburn
Afburn Jul. 11 at 3:40 PM
$ZOMDF
0 · Reply
Afburn
Afburn Jul. 11 at 3:37 PM
$ZOMDF What is the best state to own horses in? Number one is California, ranked first for equestrian activities and equine care. Its overall score is 77.46, which puts it 13.71 points ahead of Texas, number two but with a number one ranking for equestrian education.Mar 14, 2023
0 · Reply
Afburn
Afburn Jul. 11 at 3:35 PM
$ZOMDF Where is horseback riding most popular in the world? Top Destinations for Horseback Riding The Golden Circle, Iceland. ... The Sunshine Coast, Australia. ... The Golden Treasure Trail, Bulgaria. ... Banff National Park, Canada. ... Doñana National Park, Spain. ... The Ring of Kerry, Ireland. ... Cappadocia, Turkey. ... Wyoming, USA.
0 · Reply
Afburn
Afburn Jul. 11 at 3:34 PM
$ZOMDF What state is equestrian the most popular in? California No. 1: California The Golden State has 1,249 horseboarding facilities and 1,936 horseback riding trails. California also boasts the most organizations offering horse custodial services (109) and ranks first for horse rental services (205) and colleges offering equine studies (10).Dec 11, 2024
0 · Reply